Himachal Pradesh high court restrains DRL from selling BI’s diabetic drug Jardiance

Dr Reddy’s on Thursday said Himachal Pradesh high court has issued an interim injunction restraining them from manufacturing and selling generic version of German drug maker Boehringer Ingelheim‘s (BI) diabetes drug Jardiance.

The drugmaker said it is reviewing legal options including filing an appeal against the court order.

Dr Reddy’s has launched copies of Jardiance (empagliflozin), which has valid patent in India until 2025. BI has sought restraining order on manufacture and sale of the drug.

Jardiance is top-selling drug for BI in India.

  • Related Posts

    Indian Pharma Majors Plan to Invest in US

    National Harbor (US): Top Indian pharmaceutical companies, including at least three from Hyderabad, are all set to announce major investments to set up new facilities in the United States during…

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Emcure Pharmaceuticals Ltd on Tuesday reported a 24 per cent increase in consolidated net profit at ₹243.74 crore in the fourth quarter ended March 2026 on the back of robust…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Indian Pharma Majors Plan to Invest in US

    Indian Pharma Majors Plan to Invest in US

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

    Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

    National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

    World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

    World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification